Tag Archives | Market Access

payer research 6 things article

6 Ways To Ensure Payer Research Delivers

In an increasingly access driven NHS, it is of paramount importance that the payer perspective is not only captured but also leveraged. Our Market Access team has reflected on our extensive experience researching a broad range of payer audiences and come up with the following ‘musts’ for ensuring payer research sings. 1: Understanding the context of decision […]

Continue Reading
Biosimilars

The Biosimilar Challenge: It’s ‘game-on’ in the Bio Battle

The ‘biosimilar challenge’ (or ‘bio battle’) is one of the most significant commercial changes we have seen in the pharma industry. Adelphi has applied expertise and knowledge from recent research conducted around biosimilars to assess the overall impact on patients, payers and physicians alongside the commercial implications for pharma. The Emergence of Biosimilars Since the […]

Continue Reading
DeveManc-market-access

The Latest on Devolution Manchester

Manchester is the first region in the UK to have adopted central government plans to devolve funding and decision-making powers. Ten local authorities are now collaborating as the Greater Manchester Health and Social Care Partnership (GMHSC), to have autonomy over housing, skills and transport, and also control of £6 billion for health and social care […]

Continue Reading
Biosimilars_Originators

Are you ready for the biosimilar challenge?

The biosimilar market is hotter than ever. Are you ready? How can originator brands avoid getting burned and how can biosimilars maximise their opportunities? We carried out an online poll with local payers across a range of different therapy areas. Here’s what they told us… 89% have reviewed biosimilar guidelines across therapy areas 89% have […]

Continue Reading
claire-nelson

Claire Nelson becomes Research Director

We are delighted to announce that Claire Nelson has been promoted to Research Director. Claire has been with us since 2008, when she joined as a Research Executive. Over the past 8 years she has developed a wealth of experience in both qualitative and quantitative research along with special area interests in Diabetes and Immunology. For the […]

Continue Reading
DeveManc-market-access

Devolution Manchester: what’s it all about?

Manchester will be the first region in the UK to adopt central government plans to devolve funding and decision-making powers. In addition to autonomy over housing, skills and transport… a significant £6 billion for health and social care services will be put under local control. Autonomy held by 10 local authorities – the ‘Greater Manchester Strategic Partnership’ Control of health […]

Continue Reading
Private-Healthcare-Market-Research

Is pharma missing key opportunities in private healthcare?

“No decision about me, without me!” Unless you’ve been living on Mars in recent years, you’ll be well aware that the NHS mantra is supposed to demonstrate its commitment to giving patients much more say over their care and treatment. Of course, this doesn’t only apply to involvement in decision-making about medications, interventions and procedures, […]

Continue Reading